Measurement of Anticoagulation in Patients on Dabigatran, Rivaroxaban, and Apixaban Therapy by Novel Automated Thrombelastography

Background  Direct-acting oral anticoagulants (DOACs) do not require monitoring. Measurement of DOAC effect would be useful in the event of bleeding, trauma, and thromboembolism while on anticoagulation. We evaluated the effectiveness of the investigational DOAC assays on the TEG®6s Hemostasis Analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Artang, Ramin, Dias, Joao D., Walsh, Mark, Bliden, Kevin, Nielsen, Jorn D., Anderson, Maren, Thurston, Brian C., Tantry, Udaya S., Hartmann, Jan, Gurbel, Paul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718262/
https://www.ncbi.nlm.nih.gov/pubmed/34984316
http://dx.doi.org/10.1055/a-1692-1415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718262/
https://www.ncbi.nlm.nih.gov/pubmed/34984316
http://dx.doi.org/10.1055/a-1692-1415

Ejemplares similares